A sharp rise in fees associated with a popular type of drug plan is chipping away at pharmacies’ profits across the U.S.

Michael Deninger, owner of three pharmacies in Iowa, initially pocketed a profit of $9.49 after he sold a 5-milliliter bottle of Bausch & Lomb’s prescription eye drop Lotemax—which came at an initial cost $145.53. At the time of sale, Mr. Deninger said he received $7.75 from the patient in the form of a copay,...